Please provide your email address to receive an email when new articles are posted on . Percent predicted FEV 1 did not improve after systemic corticosteroid treatment. This treatment was also not ...
For much of modern medicine, inflammation was viewed as a localized response. Swelling, redness, and pain were understood as ...
– Systemic sclerosis (SSc) is a rare disease that impacts up to 75,000 people in the United States – – Approximately 80% of SSc patients may be affected by interstitial lung disease (ILD), a ...
The FDA has approved Actemra® (tocilizumab; Genentech) subcutaneous injection for slowing the rate of decline in pulmonary function in SSc-ILD. The Food and Drug Administration (FDA) has approved ...
Cost-effectiveness of NALIRIFOX compared to other first-line treatments for metastatic pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results